Gotowa bibliografia na temat „Antiretroviral agents”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Antiretroviral agents”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Antiretroviral agents"
Chaudry, Muddasar N., i David H. Shepp. "ANTIRETROVIRAL AGENTS". Dermatologic Clinics 15, nr 2 (kwiecień 1997): 319–30. http://dx.doi.org/10.1016/s0733-8635(05)70440-x.
Pełny tekst źródłaKraus, George A., Alex Melekhov, Susan Carpenter, Yvonne Wannemuhler i Jacob Petrich. "Phenanthrenequinone antiretroviral agents". Bioorganic & Medicinal Chemistry Letters 10, nr 1 (styczeń 2000): 9–11. http://dx.doi.org/10.1016/s0960-894x(99)00589-2.
Pełny tekst źródłaSiegel, Lawrence, i Roy M. Gulick. "New antiretroviral agents". Current Infectious Disease Reports 9, nr 3 (27.04.2007): 243–51. http://dx.doi.org/10.1007/s11908-007-0038-8.
Pełny tekst źródłaCambou, Mary C., i Raphael J. Landovitz. "Novel Antiretroviral Agents". Current HIV/AIDS Reports 17, nr 2 (12.02.2020): 118–24. http://dx.doi.org/10.1007/s11904-020-00486-2.
Pełny tekst źródłaHarris, Marianne. "Raltegravir: Its use in the Treatment of HIV Infection". Clinical Medicine. Therapeutics 1 (styczeń 2009): CMT.S32. http://dx.doi.org/10.4137/cmt.s32.
Pełny tekst źródła&NA;. "GUIDELINES FOR ANTIRETROVIRAL AGENTS". American Journal of Nursing 100, nr 5 (maj 2000): 17. http://dx.doi.org/10.1097/00000446-200005000-00019.
Pełny tekst źródłaCollura, Jennifer M., i Donna M. Kraus. "New pediatric antiretroviral agents". Journal of Pediatric Health Care 14, nr 4 (lipiec 2000): 183–92. http://dx.doi.org/10.1067/mph.2000.107924.
Pełny tekst źródłaOwen, Andrew, i Saye H. Khoo. "Pharmacogenetics of antiretroviral agents". Current Opinion in HIV and AIDS 3, nr 3 (maj 2008): 288–95. http://dx.doi.org/10.1097/coh.0b013e3282f7cda4.
Pełny tekst źródłaCOLLURA, J., i D. KRAUS. "New pediatric antiretroviral agents". Journal of Pediatric Health Care 14, nr 4 (lipiec 2000): 183–92. http://dx.doi.org/10.1016/s0891-5245(00)27765-1.
Pełny tekst źródłaStruble, Kimberly A., R. Douglas Pratt i Steven R. Gitterman. "Toxicity of antiretroviral agents". American Journal of Medicine 102, nr 5 (maj 1997): 65–67. http://dx.doi.org/10.1016/s0002-9343(97)00065-x.
Pełny tekst źródłaRozprawy doktorskie na temat "Antiretroviral agents"
陳惠結 i Wai-kit Chan. "The most effective method to improve antiretroviral drug adherence". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40720329.
Pełny tekst źródłaChan, Wai-kit. "The most effective method to improve antiretroviral drug adherence". Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B40720329.
Pełny tekst źródłaTerblanche, Lauren Muriel. "The knowledge about HIV/AIDS and antiretroviral treatment of patients receiving antiretroviral therapy". Thesis, Stellenbosch : Stellenbosch University, 2012. http://hdl.handle.net/10019.1/20131.
Pełny tekst źródłaENGLISH ABSTRACT: Many HIV positive patients are on antiretroviral therapy (ART) to assist in decreasing the replication of the HIV virus within the body. Adherence to this medication is important, as non- adherence can have serious repercussions. Therefore, the patients’ knowledge of ART and their disease is crucial in ensuring good adherence. A range of barriers to patient education were suspected by the researcher in this community of Delft. The high influx of patients into the clinic everyday minimized consultation time and thereby diminished the opportunity for effective patient education. Consequently, adherence to medication which is closely related to the knowledge and understanding of patients about the disease may be affected. The following research question was therefore explored: What is the knowledge of infected HIV/AIDS patients who are receiving antiretroviral treatment about HIV/AIDS and ART? The objectives set were to evaluate the patient’s knowledge of HIV/AIDS, evaluate the knowledge of ART and to determine whether there are statistical differences between the dependant and independent variables within the study. A quantitative descriptive correlational research design was applied and a convenience sample of n= 200 (8.5%) patients was selected from a population of N= 2349 at the Delft Community Health Centre. A multiple choice questionnaire comprising of mainly closed ended questions with multiple responses was used in individual interviews conducted by either the researcher or fieldworker. Reliability and validity was ensured through the consultation of experts in the fields of research methodology, statistics, HIV/AIDS and the Health Research Ethics Committee of Stellenbosch University. Permission to conduct this study was granted by the Health Research Ethics Committee of Stellenbosch University, the Provincial Regional Head for Primary Health Care Services, as well as the head of the Delft Community Health Centre. Data revealed that the participants were mainly female (n=145/72.5%), and the mean age was 37.5 years. Participants were mostly Xhosa speaking and literate, and the majority (n=112/56%), of the participants had a highest education level between grade 9 and grade 12. Many (n=73/36.5%) of the participants had been living with HIV for more than 5 years, but had been on ART for between 1 to 3 years. Knowledge was assessed by asking questions about various aspects of HIV and ART throughout the study. Scores for the 14 critical questions revealed that (n=0/0%) of the participants had good knowledge, (n=40/20%) of the participants had average knowledge and (n=160/80%) of the participants had poor knowledge. The average score for all participants for all 20 knowledge testing questions was (12.6/63%). The findings showed that the overall knowledge (n=160/80%) is poor. Basic terms and principles of HIV/AIDS and ART were not understood and serious misconceptions regarding the disease were revealed.
AFRIKAANSE OPSOMMING: Baie MIV positiewe pasiënte is op antiretrovirale terapie (ART) om te help met die vermindering van die replisering van die HIV virus in die liggaam. Gebruik van hierdie medikasie is belangrik omdat versuiming van inname ernstige gevolge kan hê. Dus, is die pasiënte se kennis van ART en hul siekte van deurslaggewende belang om volgehoue inname te verseker. ’n Reeks van hindernisse om pasiënte te onderrig, is deur die navorser in die Delftgemeenskap vermoed. Die hoë toestroming van pasiënte na die kliniek elke dag het die konsultasietyd tot die minimum beperk en daardeur die geleentheid vir effektiewe pasiëntonderrig laat verminder. Gevolglik, kan die nakoming om die medikasie te neem wat ’n noue verband toon met die kennis en begrip wat pasiënte het oor die siekte, geaffekteer word. Die volgende navorsingsvraag is gevolglik ondersoek: Wat is die kennis van geïnfekteerde HIV/VIGS pasiënte wat antiretrovirale behandeling ontvang oor HIV/VIGS en ART? Die doelwitte wat gestel is, is om die pasiënt se kennis van HIV/VIGS te evalueer, die kennis van ART te evalueer en te bepaal of daar ’n statistiese verwantskap tussen onafhanklike en afhanklike veranderlikes binne die studie is. ’n Kwantitatiewe beskrywende korrelerende navorsingsontwerp is toegepas en ’n gerieflikheidsmonster van n= 200 (8.5%) pasiënte is geselekteer uit ’n bevolking van N = 2349 by die Delftgemeenskap Gesondheidssentrum. ’n Veelkeusige vraelys wat hoofsaaklik uit geslote vrae met veelkeusige response bestaan het, is gebruik in individuele onderhoude wat deur of die navorser of veldwerker gevoer is. Betroubaarheid en geldigheid is verseker deur oorlegpleging met spesialiste op die gebied van navorsingsmetodologie, statistiek, HIV/VIGS en die Gesondheidsnavorsing se Etiese Komitee van die Universiteit van Stellenbosch. Toestemming om die navorsing te doen, is gegee deur die Gesondheidsnavorsing se Etiese Komitee van Stellenbosch Universiteit, die Provinsiale Streekshoof vir Primêre Gesondheidsdienste, asook die hoof van die Delftgemeenskap Gesondheidssentrum. Data het bewys dat die deelnemers hoofsaaklik vroulik is (n=145/72.5%) en die gemiddelde ouderdom 37.5 jaar. Deelnemers is meestal Xhosasprekend en geletterd en die meerderheid (n=112/56%) van die deelnemers se hoogste opleidingsvlak is tussen graad 9 en graad 12. Baie (n=73/36.5%) van die deelnemers het met HIV geleef vir 5 jaar, maar was op ART vir tussen 1 tot 3 jaar. Kennis is geassesseer deur vrae te stel oor verskeie aspekte van HIV en ART dwarsdeur die ondersoek. Puntetelling vir die 14 kritiese vrae het aan die lig gebring dat (n=0/0%) van die deelnemers goeie kennis het, (n=40/20%) van die deelnemers beskik oor gemiddelde kennis en (n=160/80%) van die deelnemers se kennis is gering. Die gemiddelde puntetelling vir al die deelnemers van al 20 kennisvrae wat getoets is, is (12.6/63%). Die bevindinge bewys dat die algehele kennis (n= 160/80%) gering is. Basiese terminologie en beginsels van HIV/VIGS en ART word nie begryp nie en ernstige wanopvattinge aangaande die siekte is geopenbaar.
Maseko, Batlile Paulos. "Antiretroviral treatment programme outcomes scenarios in South Africa in the next two decades". Thesis, University of Limpopo (Medunsa Campus), 2012. http://hdl.handle.net/10386/1094.
Pełny tekst źródłaGaula, M. D. "Drug adverse effects in HIV-infected patients receiving antiretroviral therapy-a pharmacovigilence approach". Thesis, University of Limpopo ( Medunsa Campus), 2011. http://hdl.handle.net/10386/396.
Pełny tekst źródłaMost pharmaceutical agents can result in side effects and toxicities that in some instances may be life threatening, especially if there is delay in their recognition. For various reasons it is therefore imperative to study adverse events associated with antiretroviral agents (ARVs). The aim of this study was to study the adverse events in adult HIV-infected patients receiving antiretroviral therapy at a public health treatment site, and to quantify the frequency of adverse events in different population subgroups. A retrospective cohort study was conducted in a sample of 99 patients (i.e. 70% females and 30% males) from a public health clinic providing antiretroviral drugs to more than 1500 patients. The reported adverse events were neurological disorders (33%), rash (17%), gastrointestinal toxicity (16%), lactic acidosis (14%), hepatitis (7%), lipodystrophy (7%), pancreatitis (5%), IRIS (3%), anaemia (1%), and gynaecomastia (1%). Based on the analysis of the presented data in this report, age, weight, gender, and pCD4 count are not the predictors for the development of lactic acidosis, pancreatitis, and peripheral neuropathy. The duration of treatment was found to be the predictor for the development of lactic acidosis, pancreatitis, and peripheral neuropathy in this study sample. More frequent and closer monitoring of the reported adverse events will be necessary for patients treated longer on ART. Information bias is possible as case data for all reported adverse effects were collected retrospectively from hand-written patient records which were not consistent and standardised.
Srasuebkul, Preeyaporn Public Health & Community Medicine Faculty of Medicine UNSW. "Evaluating monitoring strategies, short-term disease progression and rate of treatment change in HIV-infected patients commencing antiretroviral therapy in the Asia-Pacific region". Publisher:University of New South Wales. Public Health & Community Medicine, 2008. http://handle.unsw.edu.au/1959.4/41673.
Pełny tekst źródłaNikisi, Joseph. "Access to antiretroviral treatment in the public sector, in Zambia /". Access to E-Thesis, 2005. http://upetd.up.ac.za/thesis/available/etd-04282009-163207/.
Pełny tekst źródłaTogami, Hiroaki. "Comprehensive in vitro susceptibility analysis of simian retrovirus type 4 to antiretroviral agents". Kyoto University, 2013. http://hdl.handle.net/2433/179351.
Pełny tekst źródłaCasey, Ryan Edward. "Mouse strain-specific splicing of Apobec3". Digital WPI, 2006. https://digitalcommons.wpi.edu/etd-theses/950.
Pełny tekst źródłaEsposito, Francesca. "Impact of highly active antiretroviral therapy (HAART) on body composition and other anthropometric measures of HIV-infected women in a primary healthcare setting in KwaZulu-Natal : a pilot study". Thesis, Link to the online version, 2008. http://hdl.handle.net/10019/1886.
Pełny tekst źródłaKsiążki na temat "Antiretroviral agents"
Trust, Southern African AIDS, red. Access to ART: Achieving comprehensive community preparedness for improved access to ART. Johannesburg: SAT Regional Office, 2007.
Znajdź pełny tekst źródłaProgrammes, Namibia Ministry of Health and Social Services Directorate of Special. National guidelines for antiretroviral therapy. Wyd. 3. Windhoek]: Ministry of Health and Social Services, Directorate of Special Programmes, 2010.
Znajdź pełny tekst źródłaNamibia. Ministry of Health and Social Services. Directorate of Special Programmes., red. National guidelines for antiretroviral therapy. Wyd. 2. Windhoek: Republic of Namibia, Ministry of Health and Social Services, Directorate of Special Programmes, 2007.
Znajdź pełny tekst źródła(Malawi), TB/ARV Programme, red. Increasing access to antiretroviral therapy in Malawi. [Malawi: s.n., 2001.
Znajdź pełny tekst źródłaG, Shekelle Paul, Southern California Evidence-Based Practice Center/RAND. i United States. Agency for Healthcare Research and Quality., red. Antiretroviral (ARV) drug resistance in the developing world. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2007.
Znajdź pełny tekst źródłaSteinberg, Jonny. AIDS and AIDS treatment in a rural Southern African setting. Pretoria: Institute for Security Studies, 2008.
Znajdź pełny tekst źródłaMauchline, Kerry. Official government justifications and public ARV provision: A comparison of Brazil, Thailand and South Africa. Rondebosch: Centre for Social Science Research, 2008.
Znajdź pełny tekst źródłaSteinberg, Jonny. AIDS and AIDS treatment in a rural Southern African setting. Pretoria: Institute for Security Studies, 2008.
Znajdź pełny tekst źródłaInstitute of Medicine (U.S.). Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings. Scaling up treatment for the global AIDS pandemic: Challenges and opportunities. Redaktor Curran James W. Washington, DC: National Academies Press, 2005.
Znajdź pełny tekst źródłaNdubani, P. Everyone now knows about ARVs: Findings from a pre and post intervention study of a fishing community in Kazungula District, Southern Province, Zambia. London, UK: Overseas Development Institute, 2007.
Znajdź pełny tekst źródłaCzęści książek na temat "Antiretroviral agents"
Larson, Kajal B., i Edward P. Acosta. "Pharmacodynamics of Antiretroviral Agents". W Methods in Pharmacology and Toxicology, 469–504. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3323-5_19.
Pełny tekst źródłaFong, I. W. "New Antiretroviral Agents for HIV Infection". W New Antimicrobials: For the Present and the Future, 161–82. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-26078-0_12.
Pełny tekst źródłaWilby, Kyle John, Tony K. L. Kiang i Mary H. H. Ensom. "Pharmacodynamic Interactions Between Antiretrovirals and Other Agents". W Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antiretroviral Drugs, 121–31. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2113-8_7.
Pełny tekst źródłaMcIlleron, Helen, i Saye H. Khoo. "Chapter 19: Interactions between Antituberculosis and Antiretroviral Agents". W Antituberculosis Chemotherapy, 191–202. Basel: KARGER, 2011. http://dx.doi.org/10.1159/000324217.
Pełny tekst źródłaMeruelo, Daniel, Steven Degar, Nuria Amari, Yehuda Mazur, David Lavie, Brandi Levin i Gad Lavie. "Mode of Action of Hypericin as an Antiretroviral Agent and Other Relevant Findings". W Natural Products as Antiviral Agents, 91–119. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3414-3_5.
Pełny tekst źródłaKiang, Tony K. L., Kyle John Wilby i Mary H. H. Ensom. "Clinical Drug-Drug Interaction Data: Effects of Antiretroviral Agents on Co-administered Drugs". W Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antiretroviral Drugs, 79–120. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2113-8_6.
Pełny tekst źródłaKiang, Tony K. L., Kyle John Wilby i Mary H. H. Ensom. "Clinical Drug-Drug Interaction Data: Effects of Co-administered Drugs on Pharmacokinetics of Antiretroviral Agents". W Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antiretroviral Drugs, 43–78. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2113-8_5.
Pełny tekst źródłaKubin, Christine J., Barbara S. Taylor i Scott M. Hammer. "Antiretroviral Agent". W Clinical Virology, 169–214. Washington, DC, USA: ASM Press, 2016. http://dx.doi.org/10.1128/9781555819439.ch11.
Pełny tekst źródłaShirasaka, Takuma, Kazuhiro Watanabe, Hidetoshi Yoshioka, Eiji Kojima, Shizuko Aoki, Kunichika Murakami i Hiroaki Mitsuya. "Lipophilic 6-Halo-2′,3′-Dideoxypurine Nucleosides: Potential Antiretroviral Agents Targeting HIV-Associated Neurologic Disorders". W Advances in Molecular Biology and Targeted Treatment for AIDS, 323–33. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-5928-9_30.
Pełny tekst źródłaMcConnell, Michelle S., i Paul Palumbo. "HIV-1 Resistance to Antiretroviral Agents: Relevance to Mothers and Infants in the Breastfeeding Setting". W Advances in Experimental Medicine and Biology, 81–88. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-2251-8_6.
Pełny tekst źródłaStreszczenia konferencji na temat "Antiretroviral agents"
Sidorova, A. P., i A. V. Bakunovich. "ANTIRETROVIRAL DRUGS AS POTENTIAL INHIBITORS OF SARS-COV-2 Mpro". W SAKHAROV READINGS 2022: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2022. http://dx.doi.org/10.46646/sakh-2022-2-31-34.
Pełny tekst źródłaHansen, Laura, Manu Platt, Roy L. Sutliff i Rudolph L. Gleason. "The Mechanical and Structural Effects of HIV Proteins on Murine Carotid Arteries". W ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53693.
Pełny tekst źródłaLin, John, Mason Farris, Lauren Robbins, Matthew Lee, Serratt Nong i Yingguang Liu. "Abstract 1332: Antiretroviral agent inhibits proliferation and motility of BT-20 cells through inhibition of human endogenous retrovirus type K". W Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1332.
Pełny tekst źródła